Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pantaleo

Showing results (61-70 of 144) with videos related to

Pageof 15
Sort By:
Chemotherapy|October 1, 2008
Molecular imaging suggests efficacy of bevacizumab beyond the second line in advanced colorectal cancer patientsG Brandi, M Nannini, M A Pantaleo, et al.
Cancer Medicine|October 18, 2013
Gene expression of the IGF pathway family distinguishes subsets of gastrointestinal stromal tumors wild type for KIT and PDGFRACarol Beadling, Janice Patterson, Emily Justusson, et al.
Cancer Management and Research|July 17, 2019
Mechanisms of resistance to a PI3K inhibitor in gastrointestinal stromal tumors: an <i>omic</i> approach to identify novel druggable targetsGloria Ravegnini, Giulia Sammarini, Sebastian Moran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 10, 2008
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancerM A Pantaleo, M Nannini, A Maleddu, et al.
Future Oncology (London, England)|December 21, 2012
Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunctionMargherita Nannini, Annalisa Astolfi, Paola Paterini, et al.
Cancer Letters|May 15, 2004
Circadian variations of rectal cell proliferation in patients affected by advanced colorectal cancerG Brandi, C Calabrese, M A Pantaleo, et al.
British Journal of Cancer|October 2, 2008
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choiceM A Pantaleo, A Astolfi, M Nannini, et al.
Journal of Cancer Research and Clinical Oncology|January 19, 2008
Surgical debulking of gastrointestinal stromal tumors: is it a reasonable option after second-line treatment with sunitinib?M A Pantaleo, M Di Battista, F Catena, et al.
Endoscopy|March 26, 2009
Severe esophagitis in a patient with gastrointestinal stromal tumor treated with imatinibM Saponara, M Di Battista, C Lolli, et al.
BMC Genomics|November 5, 2015
Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST)Annalisa Astolfi, Milena Urbini, Valentina Indio, et al.
Pageof 15

Showing results (61-70 of 144) with videos related to

Sort By:
Pageof 15
Chemotherapy|October 1, 2008
Molecular imaging suggests efficacy of bevacizumab beyond the second line in advanced colorectal cancer patientsG Brandi, M Nannini, M A Pantaleo, et al.
Cancer Medicine|October 18, 2013
Gene expression of the IGF pathway family distinguishes subsets of gastrointestinal stromal tumors wild type for KIT and PDGFRACarol Beadling, Janice Patterson, Emily Justusson, et al.
Cancer Management and Research|July 17, 2019
Mechanisms of resistance to a PI3K inhibitor in gastrointestinal stromal tumors: an <i>omic</i> approach to identify novel druggable targetsGloria Ravegnini, Giulia Sammarini, Sebastian Moran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 10, 2008
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancerM A Pantaleo, M Nannini, A Maleddu, et al.
Future Oncology (London, England)|December 21, 2012
Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunctionMargherita Nannini, Annalisa Astolfi, Paola Paterini, et al.
Cancer Letters|May 15, 2004
Circadian variations of rectal cell proliferation in patients affected by advanced colorectal cancerG Brandi, C Calabrese, M A Pantaleo, et al.
British Journal of Cancer|October 2, 2008
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choiceM A Pantaleo, A Astolfi, M Nannini, et al.
Journal of Cancer Research and Clinical Oncology|January 19, 2008
Surgical debulking of gastrointestinal stromal tumors: is it a reasonable option after second-line treatment with sunitinib?M A Pantaleo, M Di Battista, F Catena, et al.
Endoscopy|March 26, 2009
Severe esophagitis in a patient with gastrointestinal stromal tumor treated with imatinibM Saponara, M Di Battista, C Lolli, et al.
BMC Genomics|November 5, 2015
Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST)Annalisa Astolfi, Milena Urbini, Valentina Indio, et al.
Pageof 15